PL2413718T3 - Zastosowanie kwasu arachidonowego do zmniejszenia ryzyka insulinooporności w późniejszym życiu - Google Patents

Zastosowanie kwasu arachidonowego do zmniejszenia ryzyka insulinooporności w późniejszym życiu

Info

Publication number
PL2413718T3
PL2413718T3 PL10711219T PL10711219T PL2413718T3 PL 2413718 T3 PL2413718 T3 PL 2413718T3 PL 10711219 T PL10711219 T PL 10711219T PL 10711219 T PL10711219 T PL 10711219T PL 2413718 T3 PL2413718 T3 PL 2413718T3
Authority
PL
Poland
Prior art keywords
risk
life
reduction
insulin resistance
arachidonic acid
Prior art date
Application number
PL10711219T
Other languages
English (en)
Inventor
Catherine Mace
Olivier Aprikian
Original Assignee
Nestec S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec S.A. filed Critical Nestec S.A.
Publication of PL2413718T3 publication Critical patent/PL2413718T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pediatric Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL10711219T 2009-04-01 2010-03-26 Zastosowanie kwasu arachidonowego do zmniejszenia ryzyka insulinooporności w późniejszym życiu PL2413718T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09157086 2009-04-01
EP10711219.5A EP2413718B1 (en) 2009-04-01 2010-03-26 Use of arachidonic acid for the reduction of the risk of insulin resistance later in life

Publications (1)

Publication Number Publication Date
PL2413718T3 true PL2413718T3 (pl) 2017-08-31

Family

ID=40790646

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10711219T PL2413718T3 (pl) 2009-04-01 2010-03-26 Zastosowanie kwasu arachidonowego do zmniejszenia ryzyka insulinooporności w późniejszym życiu

Country Status (15)

Country Link
US (2) US9480670B2 (pl)
EP (1) EP2413718B1 (pl)
CN (1) CN102368913A (pl)
AU (1) AU2010230362B2 (pl)
BR (1) BRPI1014923A2 (pl)
CA (1) CA2755077A1 (pl)
CL (1) CL2011002405A1 (pl)
ES (1) ES2570774T3 (pl)
MX (1) MX2011010229A (pl)
MY (1) MY161505A (pl)
PL (1) PL2413718T3 (pl)
RU (1) RU2559646C2 (pl)
SG (1) SG173914A1 (pl)
TW (1) TW201039759A (pl)
WO (1) WO2010112429A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2514435A1 (en) * 2011-04-19 2012-10-24 Nestec S.A. Infant formula for use in the prevention of cardiovascular diseases
US9636367B2 (en) * 2011-10-18 2017-05-02 Nestec S.A. Composition for use in increasing insulin sensitivity and/or reducing insulin resistance
SG11201403712XA (en) * 2011-12-27 2014-10-30 Abbott Lab Use of reduced calorie infant formula containing nucleotides and/or carotenoids for reducing adverse health effects later in life
WO2013138157A1 (en) * 2012-03-14 2013-09-19 Abbott Laboratories Nutritional compositions including rrr -alpha tocopherol and polyunsaturated fatty acids
WO2014159967A1 (en) 2013-03-13 2014-10-02 Abbott Laboratories A composition for enhancing newborn infant cognitive, brain and/or cns development and method of using same
EP2983517A1 (en) 2013-03-13 2016-02-17 Abbott Laboratories Infant nutritional product with rrr alpha-tocopherol
WO2015078974A1 (en) * 2013-11-29 2015-06-04 Nestec S.A. Infant nutrition for improvement in insulin sensitivity later in life
US20180153951A1 (en) * 2016-12-05 2018-06-07 Mead Johnson Nutrition Company Methods for Inducing Adipocyte Browning, Improving Metabolic Flexibility, and Reducing Detrimental White Adipocyte Tissue Deposition and Dysfunction
EP3645025B1 (en) 2017-06-30 2022-09-14 N.V. Nutricia Synbiotic composition for preventing atherosclerosis
EP3645023B1 (en) 2017-06-30 2022-09-14 N.V. Nutricia Synbiotic composition for preventing hyperinsulinemia and insulin resistance
CN116622514B (zh) * 2023-07-21 2023-10-20 南京师范大学 提高微生物菌体和/或微生物油脂中多不饱和脂肪酸含量的调控方法及应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2101274C (en) * 1991-01-24 1998-12-15 David J. Kyle Microbial oil mixtures and uses thereof
US6200624B1 (en) * 1996-01-26 2001-03-13 Abbott Laboratories Enteral formula or nutritional supplement containing arachidonic and docosahexaenoic acids
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
EP1039892B1 (en) * 1997-02-21 2004-04-28 Abbott Laboratories Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis
WO1998044917A1 (en) * 1997-03-27 1998-10-15 Bristol-Myers Squibb Company Use of docosahexanoic acid and arachidonic acid enhancing the growth of preterm infants
EP0880902A1 (fr) 1997-05-27 1998-12-02 Nestlé Produkte AG Procédé de traitement d'une matiére première lactosérique
PT1239022E (pt) 2001-03-09 2009-06-05 Nestle Sa Óleo contendo um ou mais ácido(s) gordo(s) polinsaturado(s) de cadeia longa provenientes de biomassa, processo de preparação, alimento, composição nutricional, cosmética ou farmacêutica contendo o mesmo
US6753350B1 (en) * 2003-03-24 2004-06-22 Bristol-Myers Squibb Company Method to reduce the incidence of intraventricular hemorrhage in preterm infants
US20070104856A1 (en) * 2003-05-05 2007-05-10 Hakon Standal Fish oils with an altered fatty acid profile, method of producing same and their use
CN1842277A (zh) * 2003-06-24 2006-10-04 堪萨斯大学医学中心 婴儿配方食品
US7759507B2 (en) * 2003-09-05 2010-07-20 Abbott Laboratories Lipid system and methods of use
US8501676B2 (en) 2004-07-19 2013-08-06 N.V. Nutricia Preparation for use of aspartate for regulating glucose levels in blood
WO2008054192A1 (en) 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
ES2537080T3 (es) * 2005-12-23 2015-06-02 N.V. Nutricia Composición que comprende ácidos grasos poliinsaturados, proteínas y manganeso y/o molibdeno para mejorar la composición de membranas celulares
WO2007100562A2 (en) * 2006-02-28 2007-09-07 Bristol-Myers Squibb Company Use of dha and ara in the preparation of a composition for reducing triglyceride levels
RU2456985C2 (ru) * 2006-02-28 2012-07-27 Бристол-Маерс Сквибб Компани Способ увеличения сухой мышечной массы и уменьшения жировой ткани
EP1932437A1 (en) * 2006-12-15 2008-06-18 Nestec S.A. Infant formula

Also Published As

Publication number Publication date
MX2011010229A (es) 2011-10-11
EP2413718A1 (en) 2012-02-08
EP2413718B1 (en) 2016-03-23
CN102368913A (zh) 2012-03-07
US20130296428A1 (en) 2013-11-07
AU2010230362A1 (en) 2011-10-06
US9480671B2 (en) 2016-11-01
WO2010112429A1 (en) 2010-10-07
CL2011002405A1 (es) 2012-03-23
US9480670B2 (en) 2016-11-01
ES2570774T3 (es) 2016-05-20
CA2755077A1 (en) 2010-10-07
RU2559646C2 (ru) 2015-08-10
RU2011144102A (ru) 2013-05-10
SG173914A1 (en) 2011-10-28
US20120029080A1 (en) 2012-02-02
TW201039759A (en) 2010-11-16
BRPI1014923A2 (pt) 2015-09-01
AU2010230362B2 (en) 2015-01-15
MY161505A (en) 2017-04-14

Similar Documents

Publication Publication Date Title
PL2413718T3 (pl) Zastosowanie kwasu arachidonowego do zmniejszenia ryzyka insulinooporności w późniejszym życiu
GB2470483B (en) Improvements in the management of medical tubing
IL209451A (en) Catheter with coil electrode
GB2482092B (en) Patient interface and aspects thereof
GB2494493B (en) Patient interface and aspects thereof
HUE037149T2 (hu) Katéter testreszabható csatlakozóval
IL208291A0 (en) Assemblies for use with an endoscope
ZA201204048B (en) Clinical syringe
EP2499034A4 (en) WHEELCHAIR
EP2619822A4 (en) STRUCTURE AND METHOD FOR EXTENDING A BATTERY LIFE
IL208678A0 (en) Reduction of catheter electrode loading
EP2478927A4 (en) CATHETER
EP2341966A4 (en) INHALER WITH HANDLED ADVERTISING MATERIALS
IL200080A0 (en) Singular wheelchair
IL217966A0 (en) Hsl inhibitors useful in the treatment of diabetes
GB0920258D0 (en) New medical agents and use thereof
IL215265A0 (en) Syringe for single use
GB0921060D0 (en) Catheter
GB0908425D0 (en) Medical use
ZA201105265B (en) Platform body
EP2455090A4 (en) MEANS TO INHIBIT THE INCREASE OF THE POSTPRANDIAL BLOOD INSULIN MIRROR
GB0912665D0 (en) Force-transmitting element for use in medical catheters
HU0900178D0 (en) Stronger paper-pallet with use of simple geometrical structure
GB201012099D0 (en) Catheter
GB201006162D0 (en) Wheelchair